title: Should off-label drugs be included as comparators in pharmacoeconomic studies?
authors.affiliation: Department of Pharmacy Systems, Outcomes, and Policy, UIC, 833 S. Wood Street (M/C 871), Chicago, IL, 60612, USA, walton@uic.edu.
authors.forename: Surrey M
authors.initials: SM
authors.lastname: Walton
authors.forename: Glen T
authors.initials: GT
authors.lastname: Schumock
mesh_terms: D003365:Costs and Cost Analysis / Q000191:economics / Q000379:methods*; D017850:Economics, Pharmaceutical; D006801:Humans; D056687:Off-Label Use / Q000191:economics*